Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK)
ConditionRadiotherapy Side Effect
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Aarhus
About this trial
The study aims to provide a setup for collecting radiotherapy-related toxicity data, loco-regional control, and overall survival data for all Danish cancer patients undergoing reirradiation with high dose intention or with the aim of local tumour control; with the ultimate aim of providing safe reirradiation to a larger group of patients. To build a reirradiation cohort database for future research
Eligibility criteria
Qualifiers
High dose reirradiation (reirradiation type I or II or repeat organ irradiation delivered with the aim of local control)
Disqualifiers
The primary and reirradiation treatments may not be quasi-simultaneous (i.e. the two treatments should be planned independently)
Trial design
Treatments tested in this trial
- Reirradiation
Treatment groups
500 Participants
are divided into 1 treatment groupLocations
This trial has no locations
Sponsors and collaborators
University of Aarhus
Lead sponsor
Source ClinicalTrials.gov